17-8289059-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_016492.5(RANGRF):c.181G>T(p.Glu61*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00449 in 1,613,690 control chromosomes in the GnomAD database, including 29 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.0036 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 27 hom. )
Consequence
RANGRF
NM_016492.5 stop_gained
NM_016492.5 stop_gained
Scores
1
4
2
Clinical Significance
Conservation
PhyloP100: 2.19
Genes affected
RANGRF (HGNC:17679): (RAN guanine nucleotide release factor) This gene encodes a protein that has been shown to function as a guanine nucleotide release factor in mouse and to regulate the expression and function of the Nav1.5 cardiac sodium channel in human. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
SLC25A35 (HGNC:31921): (solute carrier family 25 member 35) SLC25A35 belongs to the SLC25 family of mitochondrial carrier proteins (Haitina et al., 2006 [PubMed 16949250]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 17-8289059-G-T is Benign according to our data. Variant chr17-8289059-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 190845.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-8289059-G-T is described in Lovd as [Benign]. Variant chr17-8289059-G-T is described in Lovd as [Likely_pathogenic].
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RANGRF | NM_016492.5 | c.181G>T | p.Glu61* | stop_gained | 2/5 | ENST00000226105.11 | NP_057576.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RANGRF | ENST00000226105.11 | c.181G>T | p.Glu61* | stop_gained | 2/5 | 1 | NM_016492.5 | ENSP00000226105.6 |
Frequencies
GnomAD3 genomes AF: 0.00362 AC: 551AN: 152238Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
551
AN:
152238
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00400 AC: 996AN: 248904Hom.: 5 AF XY: 0.00390 AC XY: 527AN XY: 134994
GnomAD3 exomes
AF:
AC:
996
AN:
248904
Hom.:
AF XY:
AC XY:
527
AN XY:
134994
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00458 AC: 6693AN: 1461334Hom.: 27 Cov.: 32 AF XY: 0.00452 AC XY: 3284AN XY: 726980
GnomAD4 exome
AF:
AC:
6693
AN:
1461334
Hom.:
Cov.:
32
AF XY:
AC XY:
3284
AN XY:
726980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00362 AC: 551AN: 152356Hom.: 2 Cov.: 32 AF XY: 0.00353 AC XY: 263AN XY: 74498
GnomAD4 genome
AF:
AC:
551
AN:
152356
Hom.:
Cov.:
32
AF XY:
AC XY:
263
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
17
ALSPAC
AF:
AC:
15
ESP6500AA
AF:
AC:
9
ESP6500EA
AF:
AC:
46
ExAC
AF:
AC:
479
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 10, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 16, 2024 | Variant summary: RANGRF c.181G>T (p.Glu61X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, however current evidence is not sufficient to establish loss of function as a mechanism for disease. The variant allele was found at a frequency of 0.0045 in 1606716 control chromosomes in the gnomAD database (v4.1 dataset). , including 29 homozygotes. The observed variant frequency is approximately 700-fold of the estimated maximal expected allele frequency for a pathogenic variant in RANGRF causing Arrhythmia phenotype (6.3e-06). Although the variant was proposed to be related to various phenotypes in the literature, a recent study performing exhaustive genetic interpretation of reported variants in minor genes (potentially) associated with Brugada syndrome, classified the variant as benign (Campuzano_2019). The following publication have been ascertained in the context of this evaluation (PMID: 30821013). ClinVar contains an entry for this variant (Variation ID: 190845). Based on the evidence outlined above, the variant was classified as benign. - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
RANGRF-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | - | - - |
Cardiac arrhythmia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -10
Find out detailed SpliceAI scores and Pangolin per-transcript scores at